chartexchange

GERN
Geron Corp
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
1.00USD-0.040%(-0.00)34,974,672
Pre-marketNov 18, 2026 9:28:30 AM EST
1.00USD0.000%(0.00)
After-hoursNov 18, 2026 4:51:30 PM EST
0.985USD-1.461%(-0.015)
Loading…
Loading…
642.56M
Healthcare
Biotechnology
CEO
John Scarlett
HQ
Foster City, CA, USA
Previous Close
$1.00
Beta
1.42
52-Week High
$2.01 2026-02-19
52-Week Low
$0.84 2026-10-28
SMA 50
$1.16
SMA 200
$1.40
Avg. Vol 10D
13.12M
Avg. Vol 30D
14.60M
Avg. Vol 90D
11.66M
Relative Vol
2.40
644.24M
558.08M
66,951,283
0.4700%
10,000,000
21,245
Feb 24, 2027 (97d)
Nov 18, 2026
Nov 10, 2026
Nov 5, 2026
Nov 4, 2026
GERN Profile

we are a biopharmaceutical company developing first-in-class therapies for cancer. imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. imetelstat is a potent and specific inhibitor of telomerase. based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or mf, myelodysplastic syndromes, or acute myelogenous leukemia.

GERN Performance
PeriodPriceDateChangeBeta
1W1.022026-11-11-2.22%-0.587
1M1.202026-10-19-16.88%2.323
3M1.532026-08-18-34.81%2.076
6M1.232026-05-18-18.91%1.161
1Y1.112025-11-18-10.14%1.416
2Y3.782024-11-18-73.61%—
5Y1.472021-11-18-32.15%0.336
GERN Stock Summary

Geron Corp (NASDAQ:GERN) stock price today is $1.00, and today's volume is 34,974,672. GERN is down 0.260% today. The 30 day average volume is 14.60M. GERN market cap is $642.56M with 644.24M shares outstanding.